Company intelligence / Profile preview

ivWatch

Newport News, Virginia, United Statesivwatch.com ↗

Ownership: Private
Development stage: Commercial

Overview

The ivWatch Monitoring System has been clinically validated to detect IV infiltrations and extravasations at the earliest stages using non-invasive optical biosensors. It provides real-time alerts to clinicians, enabling early intervention before visible harm occurs. The system has received FDA clearance and CE Mark approval for commercial use in healthcare settings globally.

Therapeutic areas: OtherOncology
Modalities: DeviceBiosensor
Industry: Physiological Monitoring

Partnerships

ICU Medical (long-term development & commercialization agreement for EHR interoperability)

Beyond the preview

Go deeper on ivWatch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ivWatch.

Explore the full profile